CRYO-CELL INTERNATIONAL, INC. Accounts Receivable
CRYO-CELL INTERNATIONAL, INC. (CCEL) had Accounts Receivable of $6.91 million as of 2026-05-31, per its 10-Q filed 2026-07-15.
Financial Statements › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2026-07-15
- 2026-05-31: Accounts Receivable, after Allowance for Credit Loss, Current $6.91M.
- 2026-02-28: Accounts Receivable, after Allowance for Credit Loss, Current $6.82M.
- 2025-11-30: Accounts Receivable, after Allowance for Credit Loss, Current $6.85M.
- 2025-08-31: Accounts Receivable, after Allowance for Credit Loss, Current $6.83M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current | Accounts Receivable, after Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2026-05-31 | $6.91M 10-Q · filed 2026-07-15 | |
| 2026-02-28 | $6.82M 10-Q · filed 2026-04-14 | |
| 2025-11-30 | $6.85M 10-Q · filed 2026-07-15 | |
| 2025-08-31 | $6.83M 10-Q · filed 2025-10-15 | |
| 2025-05-31 | $6.93M 10-Q · filed 2026-07-15 | |
| 2025-02-28 | $7.21M 10-Q · filed 2026-04-14 | |
| 2024-11-30 | $7.31M 10-Q · filed 2026-07-15 | |
| 2024-08-31 | $6.87M 10-Q · filed 2025-10-15 | |
| 2024-05-31 | $6.83M 10-Q · filed 2025-07-15 | |
| 2024-02-29 | $6.73M 10-Q · filed 2025-04-14 | |
| 2023-11-30 | $6.58M 10-K · filed 2026-02-27 | |
| 2023-08-31 | $6.44M 10-Q · filed 2024-10-15 | |
| 2023-05-31 | $6.68M 10-Q · filed 2024-07-15 | |
| 2023-02-28 | $6.52M 10-Q · filed 2024-04-15 | |
| 2022-11-30 | $6.04M 10-K · filed 2025-02-28 | |
| 2022-08-31 | $5.35M 10-Q · filed 2023-10-12 | |
| 2022-05-31 | $5.15M 10-Q · filed 2023-07-14 | |
| 2022-02-28 | $5.15M 10-Q · filed 2023-04-21 | |
| 2021-11-30 | $5.25M 10-K · filed 2024-02-28 | |
| 2021-08-31 | $5.45M 10-Q · filed 2022-10-18 | |
| 2021-05-31 | $5.22M 10-Q · filed 2022-07-11 | |
| 2021-02-28 | $5.64M 10-Q · filed 2022-04-13 | |
| 2020-11-30 | $6.32M 10-K · filed 2023-02-28 | |
| 2020-08-31 | $6.50M 10-Q · filed 2021-10-15 | |
| 2020-05-31 | $5.97M 10-Q · filed 2021-07-15 | |
| 2020-02-29 | $5.77M 10-Q · filed 2020-04-14 | |
| 2019-11-30 | $6.10M 10-K · filed 2022-02-22 | |
| 2019-08-31 | $5.89M 10-Q · filed 2020-10-15 | |
| 2019-05-31 | $5.87M 10-K · filed 2021-03-01 | $5.76M 10-Q · filed 2019-07-15 |
| 2019-02-28 | $5.69M 10-Q · filed 2019-04-15 | |
| 2018-11-30 | $5.87M 10-Q · filed 2020-10-15 | |
| 2018-08-31 | $5.51M 10-Q · filed 2018-10-15 | |
| 2018-05-31 | $4.82M 10-Q · filed 2018-07-16 | |
| 2018-02-28 | $4.93M 10-Q · filed 2018-04-16 | |
| 2017-11-30 | $5.13M 10-K · filed 2019-02-28 | |
| 2017-08-31 | $4.86M 10-Q · filed 2017-10-16 | |
| 2017-05-31 | $4.56M 10-Q · filed 2017-07-07 | |
| 2017-02-28 | $4.45M 10-Q · filed 2017-04-13 | |
| 2016-11-30 | $4.05M 10-K · filed 2018-02-28 | |
| 2016-08-31 | $4.38M 10-Q · filed 2016-10-17 | |
| 2016-05-31 | $3.70M 10-Q · filed 2016-07-11 | |
| 2016-02-29 | $3.22M 10-Q · filed 2016-04-14 | |
| 2015-11-30 | $3.06M 10-K · filed 2017-02-28 | |
| 2015-08-31 | $4.16M 10-Q · filed 2015-10-15 | |
| 2015-05-31 | $3.71M 10-Q · filed 2015-07-15 | |
| 2015-02-28 | $4.20M 10-Q · filed 2015-04-14 | |
| 2014-11-30 | $4.07M 10-K · filed 2016-02-29 | |
| 2014-08-31 | $3.95M 10-Q · filed 2014-10-15 | |
| 2014-05-31 | $4.10M 10-Q · filed 2014-07-03 | |
| 2014-02-28 | $3.70M 10-Q · filed 2014-04-14 | |
| 2013-11-30 | $3.34M 10-K · filed 2015-03-02 | |
| 2013-08-31 | $3.58M 10-Q · filed 2013-10-15 | |
| 2013-05-31 | $3.57M 10-Q · filed 2013-07-15 | |
| 2013-02-28 | $3.36M 10-Q · filed 2013-04-15 | |
| 2012-11-30 | $2.84M 10-K · filed 2014-02-28 | $3.40M 10-K · filed 2013-02-28 |
| 2012-08-31 | $3.37M 10-Q · filed 2012-10-15 | |
| 2012-05-31 | $3.29M 10-Q · filed 2012-07-16 | |
| 2012-02-29 | $3.21M 10-Q · filed 2012-04-16 | |
| 2011-11-30 | $3.06M 10-K · filed 2013-02-28 | |
| 2011-08-31 | $2.57M 10-Q/A · filed 2011-11-07 | |
| 2010-11-30 | $2.36M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |